Ignite Creation Date:
2024-05-06 @ 1:51 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01910506
Status:
COMPLETED
Last Update Posted:
2014-01-09
First Post:
2013-07-25
Brief Title:
RDEA3170 AME Study
Sponsor:
Ardea Biosciences Inc
Organization:
Ardea Biosciences Inc
Study Overview
Official Title:
A Phase 1 Absorption Metabolism and Excretion Study of 14CRDEA3170 Orally Administered to Healthy Adult Male Subjects
Status:
COMPLETED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will determine the characteristics of absorption metabolism and excretion AME of RDEA3170 following a single 10 mg dose of RDEA3170 oral solution with 500 microcuries µCi of 14 CRDEA3170 in healthy adult male subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None